Show
Sort by
-
- Journal Article
- open access
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine.
-
- Journal Article
- A1
- open access
mRNA in cancer immunotherapy : beyond a source of antigen
-
- Journal Article
- A1
- open access
CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma
-
- Journal Article
- A1
- open access
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
-
- Journal Article
- A1
- open access
Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy
-
- Journal Article
- A1
- open access
Anti-human PD-L1 Nanobody for immuno-PET imaging : validation of a conjugation strategy for clinical translation
-
- Journal Article
- A1
- open access
Broadening the message : a nanovaccine co-loaded with messenger RNA and α-GalCer induces antitumor immunity through conventional and natural killer T cells
-
Optimized messenger RNA immunolipoplexes for cancer immunotherapy : balancing immunogenicity and adjuvancy
-
Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety
-
Co-delivery of nucleoside-modified mRNA and immunomodulators for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA